Artificial intelligence-based tools have the potential to transform health care, enabling faster and more accurate diagnosis, personalized treatment plans, new therapeutic approaches and effective disease monitoring. Artificial intelligence shows particular promise for the management of rare neurological disorders by augmenting knowledge and facilitating the sharing of expertise among physicians.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schaefer, J., Lehne, M., Schepers, J., Prasser, F. & Thun, S. The use of machine learning in rare diseases: a scoping review. Orphanet J. Rare Dis. 15, 145 (2020).
Yuan, X. et al. Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases. Brief. Bioinform. 23, bbac019 (2022).
Groza, T. et al. The Human Phenotype Ontology: semantic unification of common and rare disease. Am. J. Hum. Genet. 97, 111–124 (2015).
Lin, S. et al. An artificial intelligence-based approach for identifying rare disease patients using retrospective electronic health records applied for Pompe disease. Front. Neurol. 14, 1108222 (2023).
Visibelli, A., Roncaglia, B., Spiga, O. & Santucci, A. The impact of artificial intelligence in the odyssey of rare diseases. Biomedicines 11, 887 (2023).
Kabeya, Y. et al. Deep convolutional neural network-based algorithm for muscle biopsy diagnosis. Lab. Invest. 102, 220–226 (2022).
Dias, R. & Torkamani, A. Artificial intelligence in clinical and genomic diagnostics. Genome Med. 11, 70 (2019).
Gurovich, Y. et al. Identifying facial phenotypes of genetic disorders using deep learning. Nat. Med. 25, 60–64 (2019).
Girdea, M. et al. PhenoTips: patient phenotyping software for clinical and research use. Hum. Mutat. 34, 1057–1065 (2013).
Bakkar, N. et al. Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. Acta Neuropathol. 135, 227–247 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Rights and permissions
About this article
Cite this article
Molnar, M.J., Molnar, V. AI-based tools for the diagnosis and treatment of rare neurological disorders. Nat Rev Neurol 19, 455–456 (2023). https://doi.org/10.1038/s41582-023-00841-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-023-00841-y
